Form 4: Lyell Immunopharma Executive Sells Shares
Insider Transaction (Form 4)
Gary K. Lee, Chief Scientific Officer of Lyell Immunopharma, Inc., sold 1,457 shares of common stock on August 21, 2026 for $15.54 per share.
Summary
- Open-market sale: disposed of 1,457 Common Stock at $15.54 ($22,642) on August 21, 2026; holds 16,220 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $22,642 of stock on the open market.
Insider Transactions
Gary K. Lee — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Open-market sale | Common Stock | 1,457 | $16 | $22.6K | 16,220 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Open-market sale (1,457 shares) |
Keywords
insider transaction, Form 4, LYEL, Lyell Immunopharma, Inc., bearish, Gary K. Lee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.